Clinical trial
A Randomized, Controlled, 2-arm Parallel Group, Multi-center Study, to Evaluate Biological and Functional Changes in Healthy Smokers Switching to Tobacco Heating System 2.2 (THS 2.2) Compared to Continuing Smoking Conventional Cigarettes for 26 Weeks in an Ambulatory Setting
NCT02396381 is registered in ClinicalTrials.gov with Philip Morris Products S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, 2-arm Parallel Group, Multi-center Study, to Evaluate Biological and Functional Changes in Healthy Smokers Switching to Tobacco Heating System 2.2 (THS 2.2) Compared to Continuing Smoking Conventional Cigarettes for 26 Weeks in an Ambulatory Setting
- Lead sponsor
- Philip Morris Products S.A.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 12, 2015
- Completion date
- August 1, 2017
- Enrollment
- 1,039 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
smoking